Literature DB >> 12609126

Depression in epilepsy: a common but often unrecognized comorbid malady.

A M Kanner1, S Palac.   

Abstract

Depressive disorders (DDs) represent the most frequent psychiatric comorbidity in epilepsy (1-5). Despite their relatively high prevalence, DDs remain unrecognized and untreated in many patients with epilepsy. The purpose of this review is to examine the reasons behind the failure to recognize and treat DDs in epilepsy. We highlight the essential epidemiologic, etiopathogenic, and clinical aspects that need to be considered in the evaluation of every epileptic patient and dedicate the last section of this paper to the review of the most relevant treatment issues. If we are successful in our goals, the reader will be impressed by the significant impact of DDs on the quality of life of these patients, and by the need to investigate treatment modalities with the same scientific rigor used in the assessment of efficacy of antiepileptic drugs in the control of seizures. Copyright Â
© 2000 Academic Press. All rights reserved.

Entities:  

Year:  2000        PMID: 12609126     DOI: 10.1006/ebeh.2000.0030

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  18 in total

1.  Depression in Epilepsy Is Much More Than a Reactive Process.

Authors:  Andres M. Kanner
Journal:  Epilepsy Curr       Date:  2003-11       Impact factor: 7.500

Review 2.  [Patients with epilepsy and anxiety disorders. Diagnosis and treatment].

Authors:  S Beyenburg; D Schmidt
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

Review 3.  Transcranial magnetic stimulation for the treatment of depression in neurologic disorders.

Authors:  Felipe Fregni; Alvaro Pascual-Leone
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

4.  Creatine attenuates seizure severity, anxiety and depressive-like behaviors in pentylenetetrazole kindled mice.

Authors:  Emmanuel O Okwuofu; Gbenga E Ogundepo; Abigail M Akhigbemen; Akinpelu L Abiola; Raymond I Ozolua; Ighodaro Igbe; Ononiwu Chinazamoku
Journal:  Metab Brain Dis       Date:  2021-02-09       Impact factor: 3.584

5.  Coping While Black: Chronic Illness, Mastery, and the Black-White Health Paradox.

Authors:  Eundria A Hill-Joseph
Journal:  J Racial Ethn Health Disparities       Date:  2019-05-03

Review 6.  The impact of epilepsy on subjective health status.

Authors:  Frank Gilliam
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

Review 7.  Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs.

Authors:  J Mitchell Miller; Robert P Kustra; Alain Vuong; Anne E Hammer; John A Messenheimer
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 8.  [Emotional and affective disorders, anxiety and personality disorders in epilepsies].

Authors:  E Pauli; H Stefan
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

Review 9.  Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

10.  Severe depression as the sole symptom of affective focal status epilepticus.

Authors:  Konstantinos Dimitriadis; Thomas Pfefferkorn; Soheyl Noachtar
Journal:  BMJ Case Rep       Date:  2014-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.